Piper Sandler Initiates Coverage On Steris with Overweight Rating, Announces Price Target of $240
Piper Sandler analyst Jason Bednar initiates coverage on Steris (NYSE:STE) with a Overweight rating and announces Price Target of $240.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Ominous Death Cross Forms On Steris’s Chart
If history is any guide, there may be trouble ahead for shares of Steris (NYSE:STE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Needham Maintains Buy on Steris, Lowers Price Target to $248
Needham analyst Mike Matson maintains Steris (NYSE:STE) with a Buy and lowers the price target from $263 to $248.
Steris Q4 EPS $2.04 Beats $2.02 Estimate, Sales $1.20B Beat $1.19B Estimate
Steris (NYSE:STE) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $2.02 by 0.99 percent. This is a 25.15 percent increase over earnings of $1.63 per share from the same period
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell
• Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Recap: Steris Q3 Earnings
Steris (NYSE:STE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 04:30 PM.
Here's what investors need to know about the announcement.
Earnings
Steris beat estimated earnings by 7.61%, reporting an EPS of $2.12 versus an estimate of $1.97.